Monotherapy with a novel intervenolin derivative, AS‐1934, is an effective treatment forHelicobacter pyloriinfection-Reference-Cited by-同舟云学术

Monotherapy with a novel intervenolin derivative, AS‐1934, is an effective treatment forHelicobacter pyloriinfection

Published:2018-02-28 Issue:2 Volume:23 Page:e12470
ISSN:1083-4389
Container-title:Helicobacter
language:en
Short-container-title:Helicobacter

Author:

Ohishi Tomokazu¹,Masuda Tohru¹,Abe Hikaru²,Hayashi Chigusa³,Adachi Hayamitsu¹,Ohba Shun‐ichi¹,Igarashi Masayuki³,Watanabe Takumi²,Mimuro Hitomi⁴⁵,Amalia Eri⁶,Inaoka Daniel Ken⁶⁷,Mochizuki Kota⁸,Kita Kiyoshi⁶⁷,Shibasaki Masakatsu²,Kawada Manabu¹⁹^ORCID

Affiliation:

1. Institute of Microbial Chemistry (BIKAKEN)Numazu, Microbial Chemistry Research Foundation Numazu‐shi Shizuoka Japan

2. Institute of Microbial Chemistry (BIKAKEN)Laboratory of Synthetic Organic ChemistryMicrobial Chemistry Research Foundation Shinagawa‐ku Tokyo Japan

3. Institute of Microbial Chemistry (BIKAKEN)Laboratory of MicrobiologyMicrobial Chemistry Research Foundation Shinagawa‐ku Tokyo Japan

4. Division of BacteriologyDepartment of Infectious Diseases ControlInternational Research Center for Infectious Diseases, The Institute of Medical ScienceThe University of Tokyo Minato‐ku Tokyo Japan

5. Division of Infectious DiseaseDepartment of Infection MicrobiologyResearch Institute for Microbial DiseasesOsaka University Suita Osaka Japan

6. Department of Biomedical ChemistryThe University of Tokyo Bunkyo‐ku Tokyo Japan

7. School of Tropical Medicine and Global HealthNagasaki University Nagasaki‐shi Nagasaki Japan

8. Department of ImmunogeneticsInstitute of Tropical MedicineNagasaki University Nagasaki‐shi Nagasaki Japan

9. Institute of Microbial Chemistry (BIKAKEN)Laboratory of OncologyMicrobial Chemistry Research Foundation Shinagawa‐ku Tokyo Japan

Funder

Japan Society for the Promotion of Science

Japan Agency for Medical Research and Development

Shimabara Science Promotion Foundation

Japan Foundation for Applied Enzymology

Publisher

Wiley

Subject

Infectious Diseases,Gastroenterology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hel.12470

Reference42 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Helicobacter pylori and gastrointestinal tract adenocarcinomas

3. Appropriate First-Line Regimens to Combat Helicobacter pylori Antibiotic Resistance: An Asian Perspective

4. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection

5. Current recommendations forHelicobacter pyloritherapies in a world of evolving resistance

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel therapeutic regimens against Helicobacter pylori: an updated systematic review;Frontiers in Microbiology;2024-06-07

2. Modern knowledge on pathogenesis, diagnosis and treatment of helicobacter infection;Experimental and Clinical Gastroenterology;2021-12-10

3. Mitochondrial complex I inhibitors suppress tumor growth through concomitant acidification of the intra- and extracellular environment;iScience;2021-12

4. The therapeutic potential of mitochondrial toxins;The Journal of Antibiotics;2021-06-23

5. Synthesis and Structure−Activity Relationship Study of Intervenolin, an Antitumor and Anti-Helicobacter pylori Quinolone Natural Product;HETEROCYCLES;2021